Moxifloxacin HCL 400 MG tablet UD 50S
Ended Awarded Last action
- Contract number
- SPE2DR26F8NH3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,470
Award facts
- Contract value 100% obligated
- $4,470.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $4,470.25 delivery order to Amerisourcebergen Drug Corp on April 21, 2026, for moxifloxacin HCL 400 mg tablet unit dose packs (50 count), firm fixed price, with an ultimate completion date of April 22, 2026.
Place of performance is Conshohocken, PA. No set-aside was used for this order.
Quick answers
Who was awarded contract SPE2DR26F8NH3?
SPE2DR26F8NH3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 21, 2026.
How much is contract SPE2DR26F8NH3 worth?
The government has obligated $4,470 on SPE2DR26F8NH3.
Is contract SPE2DR26F8NH3 an order under another contract?
Yes. SPE2DR26F8NH3 is a delivery order under SPE2DR25D3517, an indefinite delivery contract.
Was contract SPE2DR26F8NH3 competed?
The extent of competition for SPE2DR26F8NH3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award